Literature DB >> 26084576

[Hemoglobin disorders].

R Dickerhoff1.   

Abstract

Hemoglobin disorders such as the thalassemias and sickle cell disease have been present in Germany since the arrival of immigrants from the eastern Mediterranean region, Africa, and Asia in the 1950s. These hereditary diseases not only require very complex treatment, but also render screening for asymptomatic carriers necessary, in order to prevent the birth of an affected child in the next generation. Pediatricians, internists, general practitioners, and gynecologists have to rise to this challenge.

Entities:  

Mesh:

Year:  2015        PMID: 26084576     DOI: 10.1007/s00108-015-3663-6

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  28 in total

1.  Hemoglobin sickle cell disease complications: a clinical study of 179 cases.

Authors:  François Lionnet; Nadjib Hammoudi; Katia Stankovic Stojanovic; Virginie Avellino; Gilles Grateau; Robert Girot; Jean-Philippe Haymann
Journal:  Haematologica       Date:  2012-02-07       Impact factor: 9.941

2.  The morphological diagnosis of congenital dyserythropoietic anemia: results of a quantitative analysis of peripheral blood and bone marrow cells.

Authors:  Hermann Heimpel; Kerstin Kellermann; Nadine Neuschwander; Josef Högel; Klaus Schwarz
Journal:  Haematologica       Date:  2010-04-26       Impact factor: 9.941

Review 3.  [Problems of adult sickle cell patients in Germany].

Authors:  R Dickerhoff; A von Rücker; G Maschmeyer; H Heimpel
Journal:  Dtsch Med Wochenschr       Date:  2009-05-20       Impact factor: 0.628

Review 4.  Hydroxyurea for the treatment of sickle cell anemia.

Authors:  Orah S Platt
Journal:  N Engl J Med       Date:  2008-03-27       Impact factor: 91.245

5.  The diagnostic dilemma of congenital unstable hemoglobinopathies.

Authors:  Amber M Yates; Nicole A Mortier; Kristina S Hyde; Jane S Hankins; Russell E Ware
Journal:  Pediatr Blood Cancer       Date:  2010-12-15       Impact factor: 3.167

6.  Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids.

Authors:  Divyanshoo R Kohli; Yunfang Li; Sergey G Khasabov; Pankaj Gupta; Lois J Kehl; Marna E Ericson; Julia Nguyen; Vinita Gupta; Robert P Hebbel; Donald A Simone; Kalpna Gupta
Journal:  Blood       Date:  2010-03-19       Impact factor: 22.113

7.  The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS).

Authors:  Ersi Voskaridou; Dimitrios Christoulas; Antonios Bilalis; Eleni Plata; Konstantinos Varvagiannis; George Stamatopoulos; Klio Sinopoulou; Aggeliki Balassopoulou; Dimitris Loukopoulos; Evangelos Terpos
Journal:  Blood       Date:  2009-11-10       Impact factor: 22.113

8.  Influence of sickle cell disease and treatment with hydroxyurea on sperm parameters and fertility of human males.

Authors:  Isabelle Berthaut; Geoffroy Guignedoux; Frederique Kirsch-Noir; Vanina de Larouziere; Celia Ravel; Dora Bachir; Frédéric Galactéros; Pierre-Yves Ancel; Jean-Marie Kunstmann; Laurence Levy; Pierre Jouannet; Robert Girot; Jacqueline Mandelbaum
Journal:  Haematologica       Date:  2008-05-27       Impact factor: 9.941

Review 9.  World distribution, population genetics, and health burden of the hemoglobinopathies.

Authors:  Thomas N Williams; David J Weatherall
Journal:  Cold Spring Harb Perspect Med       Date:  2012-09-01       Impact factor: 6.915

Review 10.  The α-thalassemias.

Authors:  Frédéric B Piel; David J Weatherall
Journal:  N Engl J Med       Date:  2014-11-13       Impact factor: 91.245

View more
  1 in total

Review 1.  [Diagnostics and treatment of preoperative anemia].

Authors:  C Rosenthal; C von Heymann; L Kaufner
Journal:  Anaesthesist       Date:  2019-08       Impact factor: 1.041

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.